Costs of restatement and related legal activities. These expenses consist primarily of investigation, audit, legal and other professional fees related to the 2006-2007 stock option investigation and related litigation, as well as recoveries received from third parties. The Company excludes these costs and recoveries from its non-GAAP measures primarily because the Company believes that these non-recurring costs and recoveries have no direct correlation to the operation of the Company’s core business.
Non-cash interest expense on convertible notes. The Company incurs non-cash interest expense related to its convertible notes. The Company excludes non-cash interest expense related to its convertible notes to provide more accurate comparisons of the Company’s results with other peer companies and to more accurately reflect the Company’s ongoing operations.
Reversal of one-time litigation costs. These adjustments are a one-time litigation cost reversal of prior litigation costs accrued related to previously awarded costs that the Company was required to pay in connection with the SK hynix and Micron Technology litigation. The Company excludes these reversals from its non-GAAP measures because the Company believes that these reversals have no direct correlation to the operations of the Company’s core business and they are a one-time event.
Severance costs. These expenses relate to the separation payment to the Company’s former chief executive officer. The Company excludes these costs from its non-GAAP measures because the Company believes that these non-recurring costs have no direct correlation to the operations of the Company’s core business.
Income tax adjustments. For purposes of internal forecasting, planning and analyzing future periods that assume net income from operations, the Company estimates a fixed, long-term projected tax rate of approximately 36 percent, which consists of estimated U.S. federal and state tax rates, and excludes tax rates associated with certain items such as withholding tax, tax credits and deferred tax asset valuation allowance. Accordingly, the Company has applied the 36 percent tax rate to its non-GAAP financial results for all periods to assist the Company’s planning for future periods. The Company has provided below a reconciliation of its GAAP provision for income taxes and GAAP effective tax rate to the assumed non-GAAP provision for income taxes and non-GAAP effective tax rate.
On occasion in the future, there may be other items, such as significant gains or losses from contingencies that the Company may exclude in deriving its non-GAAP financial measures if it believes that doing so is consistent with the goal of providing useful information to investors and management.
This release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995 including relating to Rambus’ expectations regarding revenue for the fourth quarter of 2014 and estimated, fixed, long-term projected tax rates. Such forward-looking statements are based on current expectations, estimates and projections, management’s beliefs and certain assumptions made by Rambus’ management. Actual results may differ materially. Rambus’ business generally is subject to a number of risks which are described more fully in Rambus’ periodic reports filed with the Securities and Exchange Commission. Rambus undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date hereof.
About Rambus Inc.
Rambus brings invention to market. Our customizable IP cores, architecture licenses, tools, services, and training improve the competitive advantage of our customers’ products while accelerating their time-to-market. Rambus products and innovations capture, secure and move data. For more information, visit www.rambus.com.
Condensed Consolidated Balance Sheets
|Cash and cash equivalents||$||125,686||$||338,696|
|Prepaids and other current assets||7,959||8,253|
|Total current assets||285,563||398,371|
|Intangible assets, net||95,694||117,172|
|Property, plant and equipment, net||65,899||72,642|
|Deferred taxes, long-term||560||4,797|
|LIABILITIES & STOCKHOLDERS’ EQUITY|
|Accrued salaries and benefits||11,840||33,448|
|Convertible notes, short-term||—||164,047|
|Other accrued liabilities||8,739||8,346|
|Total current liabilities||26,276||212,842|
|Convertible notes, long-term||113,692||109,629|
|Long-term imputed financing obligation||39,148||39,349|
|Other long-term liabilities||10,441||11,330|
|Total long-term liabilities||163,281||160,308|
|Total stockholders’ equity||377,600||340,229|
|Total liabilities and stockholders’ equity||$||567,157||$||713,379|
Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
Three Months Ended
Nine Months Ended
|Contract and other revenue||5,703||2,281||17,131||3,835|
|Operating costs and expenses:|
|Cost of revenue (1)||10,540||8,958||31,199||22,857|
|Research and development (1)||27,014||27,553||81,580||91,178|
|Marketing, general and administrative (1)||18,200||18,698||55,639||57,956|
|Impairment of goodwill and long-lived assets||—||8,070||—||8,070|
|Gain from sale of intellectual property||—||—||(170||)||(1,388||)|
|Gain from settlement||(510||)||(179||)||(1,530||)||(179||)|
|Total operating costs and expenses||55,244||64,229||166,757||181,829|
|Interest income and other income (expense), net||(549||)||66||(432||)||(1,373||)|
|Interest and other income (expense), net||(3,608||)||(8,486||)||(22,187||)||(24,663||)|
|Income (loss) before income taxes||10,860||579||35,574||(8,413||)|
|Provision for income taxes||5,347||6,304||17,214||15,558|
|Net income (loss)||$||5,513||$||(5,725||)||$||18,360||$||(23,971||)|
|Net income (loss) per share:|
|Weighted average shares used in per share calculation|